Cargando…

Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report

Lenalidomide has been developed as the derivative of thalidomide that has fewer side effects. We herein report a rare case of castration‐resistant prostate cancer successfully maintained using lenalidomide for multiple myeloma.

Detalles Bibliográficos
Autores principales: Shimokihara, Kota, Kawahara, Takashi, Suzuki, Taisei, Mochizuki, Taku, Takamoto, Daiji, Teranishi, Jun‐ichi, Miyoshi, Yasuhide, Yumura, Yasushi, Yao, Masahiro, Uemura, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799614/
https://www.ncbi.nlm.nih.gov/pubmed/29445483
http://dx.doi.org/10.1002/ccr3.1328
_version_ 1783298035025969152
author Shimokihara, Kota
Kawahara, Takashi
Suzuki, Taisei
Mochizuki, Taku
Takamoto, Daiji
Teranishi, Jun‐ichi
Miyoshi, Yasuhide
Yumura, Yasushi
Yao, Masahiro
Uemura, Hiroji
author_facet Shimokihara, Kota
Kawahara, Takashi
Suzuki, Taisei
Mochizuki, Taku
Takamoto, Daiji
Teranishi, Jun‐ichi
Miyoshi, Yasuhide
Yumura, Yasushi
Yao, Masahiro
Uemura, Hiroji
author_sort Shimokihara, Kota
collection PubMed
description Lenalidomide has been developed as the derivative of thalidomide that has fewer side effects. We herein report a rare case of castration‐resistant prostate cancer successfully maintained using lenalidomide for multiple myeloma.
format Online
Article
Text
id pubmed-5799614
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57996142018-02-14 Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report Shimokihara, Kota Kawahara, Takashi Suzuki, Taisei Mochizuki, Taku Takamoto, Daiji Teranishi, Jun‐ichi Miyoshi, Yasuhide Yumura, Yasushi Yao, Masahiro Uemura, Hiroji Clin Case Rep Case Reports Lenalidomide has been developed as the derivative of thalidomide that has fewer side effects. We herein report a rare case of castration‐resistant prostate cancer successfully maintained using lenalidomide for multiple myeloma. John Wiley and Sons Inc. 2018-01-11 /pmc/articles/PMC5799614/ /pubmed/29445483 http://dx.doi.org/10.1002/ccr3.1328 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Shimokihara, Kota
Kawahara, Takashi
Suzuki, Taisei
Mochizuki, Taku
Takamoto, Daiji
Teranishi, Jun‐ichi
Miyoshi, Yasuhide
Yumura, Yasushi
Yao, Masahiro
Uemura, Hiroji
Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report
title Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report
title_full Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report
title_fullStr Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report
title_full_unstemmed Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report
title_short Lenalidomide decreased the PSA level for castration‐resistant prostate cancer: a case report
title_sort lenalidomide decreased the psa level for castration‐resistant prostate cancer: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799614/
https://www.ncbi.nlm.nih.gov/pubmed/29445483
http://dx.doi.org/10.1002/ccr3.1328
work_keys_str_mv AT shimokiharakota lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT kawaharatakashi lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT suzukitaisei lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT mochizukitaku lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT takamotodaiji lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT teranishijunichi lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT miyoshiyasuhide lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT yumurayasushi lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT yaomasahiro lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport
AT uemurahiroji lenalidomidedecreasedthepsalevelforcastrationresistantprostatecanceracasereport